Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax's vaccine has been available since 2022 in the U.S. after the FDA granted its emergency use. "We look forward to ...

Shares of Novavax Inc. (NVAX) traded 20% higher on Wednesday morning after the company expressed optimism about receiving ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...